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Abstract
A 61-year-old man was referred to our hospital to treat extrahepatic portal venous obstruction. Endoscopic injection
sclerotherapy (EIS) was performed for the esophageal varices; however, the patient returned with massive hematemesis
from gastric varices 6 months after treatment. Although the varices were treated with EIS, gastric devascularization and
splenectomy concomitant with shunt surgery were required to treat uncontrollable, frequent diarrhea and abdominal
distension. Because the splenic vein, left gastric vein, left portal vein, and inferior vena cava were inadequate
for anastomosis, an epiploic gonadal vein bypass was performed. The bypass graft remains patent 7 months
after surgery, and the patient is in good health without any clinical symptoms. We describe a new bypass
route for extrahepatic portal venous obstruction.
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Background
Extrahepatic portal venous obstruction (EHPVO) is a dis-
order characterized by chronic blockage of portal venous
flow that results in portal hypertension, and its associated
elevated portal venous pressure leads to gastroesophageal
variceal hemorrhage [1–4]. Shunt surgery is indicated for
refractory or complicated cases of this disease [5–13]. Sev-
eral surgical shunts have been reported, and currently,
mesenteric-left portal vein bypass (MLPVB) is the primary
shunt used for EHPVO because it is the most physiologic
shunt and it restores hepatic blood flow [5–10, 12]. How-
ever, MLPVB is limited to those with favorable anatomy,
and it cannot be used in cases in which the left portal vein
(LPV) is occluded or strictured. We report a case of a se-
vere adult-onset case of EHPVO in which epiploic gonadal





Severe diarrhea and abdominal distention.
Past history
Bilateral common iliac artery stenting for the arterio-
sclerosis obliterans at the age of 57.
Present illness
A 61-year-old male presented with severe diarrhea
and abdominal distention. Computed tomography
(CT) showed EHPVO, and he was referred to our
hospital for treatment. Although laboratory test re-
sults showed a low albumin level of 2.7 g/dL and a
decreased platelet count of 9.8 × 104/μL due to
splenomegaly, liver function tests, including the serum
ammonia level, were normal. The protein C level
(65 %) and protein S level (105 %) were normal. Fur-
ther, the patient had no previous history of abdominal
surgery or trauma, and the cause of EHPVO was sus-
pected to be idiopathic. Upper gastrointestinal endos-
copy revealed linear varices without a red color sign
from gastric cardia to the middle part of the esopha-
gus, and endoscopic injection sclerotherapy (EIS) was
performed. He presented 6 months after the endoscopic
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treatment with massive hematemesis and was readmitted
to our hospital. Endoscopy showed bead-shaped moderate
varices with a red color sign and active bleeding from gas-
tric varices. EIS was successfully performed. CT showed
an occluded extrahepatic portal vein and markedly dilated
left gastric vein (LGV) and mesenteric veins (Fig. 1). Cav-
ernous transformation around the main portal vein and
inferior vena cava (IVC) was seen. Because the patient’s
activity of daily life was severely impaired by frequent diar-
rhea and abdominal distention and because the risk of
rebleeding was high, gastric devascularization and splen-
ectomy concomitant with shunt surgery was planned.
Before the surgery, the markedly dilated LGV and IVC
were the candidates for the proximal and distal sites of the
shunt, respectively, because the splenic vein (SpV) and
LPV had become constricted and were inadequate for
anastomosis (Fig. 1).
Surgical findings
Firstly, gastric devascularization and splenectomy were
performed. However, the dilatation of epiploic vein in
the greater omentum got worse after the devasculariza-
tion, and shunt surgery was planned. Nets of collateral
vessels were found circling the LGV and IVC, and it was
difficult to handle these vessels. Severe inflammation
after EIS was also seen around the LGV. The epiploic
vein was markedly dilated, so it was chosen as the prox-
imal site of the bypass. Instead of using the IVC for the
distal site of the bypass, the left gonadal vein was
chosen. The anastomosis was constructed end-to-end
with a single running suture using 6–0 Prolene (Fig. 2).
Postoperative course
The postoperative course was uneventful, and the pa-
tient was discharged 14 days after surgery. CT 3 months
Fig. 1 Schema of extrahepatic portal venous obstruction. Extrahepatic main portal vein (PV) was occluded (between black arrows). The left portal
vein was constricted, although it was perfused by cavernous transformation, and the patient’s splenic vein (SpV) was also constricted. The left
gastric vein (LVG) and mesenteric vein (MV) were markedly dilated. SMV superior mesenteric vein
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after the surgery showed disappearance of ascites and
mesenteric edema (Fig. 3). The dilatation of the mesen-
teric vein was also reduced. The bypass graft remains
patent 7 months after surgery, and the patient is in good
health without any clinical symptoms.
Discussion
EHPVO causes portal hypertension, and up to 70 % of
the etiological factors of this disease remain idiopathic
[1–3]. Almost 90 % of children with EHPOV present
with variceal bleeding, and the remaining 10 % present
with splenomegaly [2]. Unlike patients with chronic
liver disease, those with EHPVO have preserved liver
function. Therefore, mortality is mainly due to variceal
bleeding, and endoscopic therapy, either EIS or endo-
scopic variceal ligation, is indicated to treat the esopha-
geal varices [2]. Endoscopic therapy has been reported
to be effective for controlling acute bleeding from
esophageal varices in 80–90 % of patients [1]. However,
endoscopic therapy does not decrease the elevated
portal venous pressure, or, as in the current case, resolve
other symptoms due to portal venous hypertension, such
as ascites and diarrhea. Therefore, in refractory or compli-
cated cases, shunt surgery is indicated. High long-term
patency rates, ranging from 89 to 97 %, have been re-
ported [6]. To prevent the shunt thrombosis, low doses of
heparin during the first week followed by antiplatelet
agents for 3–6 months is recommended [6]. A successful
shunt decreases the portal venous pressure and improves
most of the clinical symptoms. Shunt surgery is classified
as “selective” or “nonselective”. Selective shunts are usu-
ally recommended because nonselective shunts, such as
the mesocaval shunt, have been associated with a signifi-
cant risk of hepatic encephalopathy compared with select-
ive shunts [6]. Distal splenorenal shunt and MLPVB have
been reported to be the representative selective shunts
[12, 13]. The distal splenorenal shunt, first described in
1967, has a lower incidence of clinically significant post-
shunt encephalopathy [13]. One problem with the sple-
norenal shunt is that it cannot be performed in almost
Fig. 2 Epiploic gonadal bypass. a Intraoperative photograph showing end-to-end anastomosis of the epiploic and left gonadal veins. b, c Postoperative
computed tomography showing patent and well-dilated epiploic vein (solid arrow) and left gonadal vein (dotted arrow)
Fig. 3 Preoperative CT (a) and postoperative CT (b). CT 3 months after the surgery showed disappearance of ascites and mesenteric edema. The
dilatation of the mesenteric vein was reduced (white arrow)
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one-third of cases due to a small or blocked SpV [14, 15].
Another selective shunt, MLPVB, was first performed by
de Ville de Goyet et al. in 1992 in a 3-year-old patient with
extrahepatic portal vein thrombosis after a partial liver
transplant [12]. This shunt restores mesenteric blood flow
to the liver through the Rex recess, and it is the most
physiologic shunt. In the current case, however, preopera-
tive CT showed the SpV and LPV were narrowed. Further,
during laparotomy, an enlarged LGV, which was the first
candidate for the proximal site of anastomosis, could not
be handled and mobilized because of severe inflammation
and nets of collateral vessels around it. Therefore, the epi-
ploic and gonadal veins were chosen as anastomosis sites
in this case. These vessels were much easier to handle and
mobilize than the LGV and IVC. Autogenous epiploic and
gonadal veins have not been used in shunt procedures to
date, and this is the first case report. Although MLPVB
and distal splenorenal shunts remain the first candidates
for shunt surgery, epiploic gonadal vein bypass might be
an option, especially in cases with narrowed LPV and SpV.
Conclusions
Epiploic gonadal vein bypass could be a new candidate
of bypass route for EHPVO patients.
Consent
Informed consent was obtained from the patient for publi-
cation of this Case Report and any accompanying images.
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